Decipher Biosciences
Business Services · California, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
6925 Lusk Blvd Ste 200, San Diego, Calif...Phone Number
(888) 792-1601Website
www.decipherbio.comRevenue
$39 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Decipher Biosciences
Decipher Biosciences is a commercial-stage precision oncology company committed to improving patient care, initially focused on urologic cancers. The company's novel prostate cancer genomic test, Decipher Prostate, provides valuable information about the underlying biology of a patient's tumor, assisting physicians in their selection of an optimal therapy. The company's differentiated approach measures the biological activity of a patient's entire tumor genome, known as whole transcriptome analysis, and applies proprietary machine learning algorithms to help physicians improve therapy selection and accelerate adoption of new therapies into the standard of care. Decipher Biosciences is headquartered in San Diego, California.Explore more
Decipher Biosciences Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Decipher Biosciences your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Decipher Biosciences had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Decipher Biosciences has recently received funding, and reach out quickly before it becomes old news!
Decipher Biosciences, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Decipher Biosciences
Funding: Get notified immidiatlly once Decipher Biosciences has new funding data
Product Launch: Get notified when Decipher Biosciences launches new products
Earning: See what the market has to say on Decipher Biosciences recently announced quarterly report
Check out if Decipher Biosciences is spiking on competitors!
Recommended Actions
Find VP level buyers at Decipher Biosciences
Find 2 more new buyers
Compare Similar Companies to Decipher Biosciences
Compare insights from companies similar to Decipher Biosciences, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Decipher Biosciences is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Decipher Biosciences is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Decipher Biosciences.
Decipher Biosciences Tech Stack
A closer look at the technologies used by Decipher Biosciences
Most Recent Scoops
Mergers & Acquisitions (M&A)
Initial Public Offering (IPO)
IPO
New Hire
Executive Move
Tina Nova has been named Chief Executive Officer.
Project
Decipher Biosciences has expressed interest in integrating applications with Salesforce via REST/SOAP.
Integration, Request for Proposal (RFP), Sales
Left Company
Executive Move
Executive Moves, Left Company
Decipher Biosciences News & Media
Veracyte Announces Expanded Availability of Decipher Prostate Test to Patients with Metastatic Prostate Cancer
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)---- $VCYT--Veracyte Announces Expanded Availability of Decipher Prostate Test to Patients with Metastatic Prostate CancerVeracyte Announces Multiple Abstracts Demonstrating Power of Decipher Testing To Fuel New Prostate and Bladder Cancer Insights Will Be Presented at AUA Annual Meeting
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)---- $VCYT--Veracyte Announces Multiple Abstracts Demonstrating Power of Decipher Testing Will Be Presented at AUA Annual MeetingVeracyte Announces Eight Abstracts Highlighting Performance and Clinical Utility of Its Decipher and MRD Tests in Urologic Cancers To Be Presented at EAU25
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)---- $VCYT--Veracyte Announces 8 Abstracts Highlighting Performance and Utility of Its Decipher and MRD Tests in Urologic Cancers To Be Presented at EAU25New Data at ASCO GU Show Power of Veracyte’s Decipher Tests to Improve Patient Care and Its GRID Tool to Advance Prostate and Bladder Cancer Research
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)---- $VCYT--New Data at ASCO GU Show Power of Veracyte’s Decipher Tests to Improve Patient Care and Its GRID Tool to Advance Prostate and Bladder Cancer Research
Read more news
Top Business Services Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Decipher Biosciences
Sign Up For FreeTo access detailed company insights
Decipher Biosciences is a commercial-stage precision oncology company committed to improving patient care, initially focused on urologic cancers. The company's novel prostate cancer genomic test, Decipher Prostate, provides valuable information about the underlying biology of a patient's tumor, assisting physicians in their selection of an optimal... Read More
